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Abstract
Apoptosis is a fundamental biologic process by which
metazoan cells orchestrate their own self-demise. Ge-
netic analyses of the nematode C elegans identified
three core components of the suicide apparatus which
include CED-3, CED-4, and CED-9. An analogous set of
core constituents exists in mammalian cells and in-
cludes caspase-9, Apaf-1, and bcl-2/x , respectively.L
CED-3 and CED-4, along with their mammalian counter-
parts, function to kill cells, whereas CED-9 and its
mammalian equivalents protect cells from death. These
central components biochemically intermingle in a
ternary complex recently dubbed the ‘‘apoptosome.’’
The C elegans protein EGL-1 and its mammalian coun-
terparts, pro-apoptotic members of the bcl-2 family,
induce cell death by disrupting apoptosome interac-
tions. Thus, EGL-1 may represent a primordial signal
integrator for the apoptosome. Various biochemical
processes including oligomerization, adenosine
triphosphate ATP/dATP binding, and cytochrome c in-
teraction play a role in regulating the ternary death
complex. Recent studies suggest that cell death recep-
tors, such as CD95, may amplify their suicide signal by
activating the apoptosome. These mutual associations
by core components of the suicide apparatus provide a
molecular framework in which diverse death signals
likely interface. Understanding the apoptosome and its
cellular connections will facilitate the design of novel
therapeutic strategies for cancer and other disease
states in which apoptosis plays a pivotal role.
Keywords: apoptosis, apoptosome, cell death, death receptor.
Introduction
Neoplasia literally means new growth and can emanate
from either increased cell proliferation or decreased cell
death. Malignant neoplasms are the consequence of accu-
mulated mutations in genes that regulate the birth or death
[ ]of cells 1 . Whereas mitosis is the organized process by
which individual cells replicate, its antithesis, apoptosis, is
the equally methodical process by which cells disintegrate.
Components of the apoptotic pathway are conserved
throughout evolution in organisms as diverse as worms,
[ ]flies, mammals, and possibly even plants 2–4 . Apoptosis
plays a fundamental role in the development of multicellular
organisms, eliminating excess cells and allowing for tissue
remodeling, a vivid example of which is the assimilation of a
tadpole’s tail during metamorphosis into a frog. In nema-
todes, which are the subject of extensive developmental
research, each cell can be accounted for and monitored,
thus revealing a predictable pattern of programmed cell
death. Similarly, in the developing vertebrate nervous sys-
tem, numerous identical ganglia containing vast numbers of
cells are generated, but only the ganglia serving the many
muscles and sensory receptors of the arms and legs sur-
vive; in the remaining ganglia, supernumerary cells are
faithfully eliminated. In essence, apoptosis is a form of
premeditated cell murder that is genetically encoded and,
generally, benefits the metazoan organism.
Derangements of apoptosis, however, do occur and can
have deleterious consequences as exemplified by several
human diseases including cancer, neurodegenerative disor-
[ ]ders, and acquired immunodeficiency syndrome 5 . In the
case of cancer, a neoplasm may form by an aberrant
overproliferation of cells. Conversely, a defect in the cell
death machinery may promote a net increase in cell survival
and thus disrupt overall homeostasis, leading to cancer. In
fact, the first component of the cell death pathway identified
was bcl-2, which was discovered due to its role in B-cell
malignancies, in which a chromosomal abnormality causes
[ ]overexpression of the protein 6 . The identification of bcl-2
defined a new class of proto-oncogene, which, instead of
enhancing cell proliferation, functioned to block cell death.
Therefore, considering the role of apoptosis in human dis-
ease, and preeminently cancer, modulation of the suicide
threshold may have immense therapeutic potential.
Recently, there has been a tremendous growth in the
number of molecular players in the cell death arena. These
[ ]include, for example, over 14 caspases 7 , at least 23 bcl-2
[ ] (family members 6 , and 6 death receptor/ ligand pairs with
) [ ]a few decoys tossed in to make it interesting 8,9 . What
are we to make of this apparent cacophony of suicide
regulators? In The Selfish Gene, Dawkins described multi-
cellular organisms as ‘‘survival machines,’’ built and pro-
grammed by the self-seeking, self-replicating, and self-suffi-
cient hereditary particles we commonly refer to as genes.
Inspired by this concept, I use the metaphor of a machine to
try to understand, describe, and categorize the inner work-
[ ]ings of the apoptosis pathway 10,11 . In this regard, the cell
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( )death machine comprises an engine or effectors , an igni-
( ) ( )tion or activators , and a set of brakes or inhibitors .
In brief, it is becoming apparent that caspases, a family
of proapoptotic cysteine proteases, make up the effector
arm or engine of the cell death machine. They are ex-
pressed as zymogens, and upon protolytic processing, gen-
erate active dimeric species. The ignition or activators of the
pathway are quite diverse and include cell-surface death
( [ ])receptors such as CD95 Fas/APO-1 or the apoptotic pro-
( ) (tease activating factor-1 Apaf-1 or its C elegans counter-
)part CED-4 . And finally, the brakes of the cell death ma-
)chine are primarily divided into two groups: 1 prosurvival
)members of the bcl-2 family, and 2 more direct caspase
( )regulators such as the inhibitor of apoptosis IAP family.
Although a survey of the various components of the death
pathway is beyond the scope of this article, please refer to
[ ]other recent review articles 6–8,11–13 .
Although numerous suicide regulators continue to be
discovered, all yearning for the spotlight, the ‘‘heart and
soul’’ of the cell death machine has essentially been estab-
lished. Pioneering genetic studies using the C elegans
model system have opened up the field of apoptosis, once
harboring phenomenology, to hard-core molecular biology
[ ]14–16 . These powerful genetic screens identified three
genes, ced-3, ced-4, and ced-9, that are important in the
regulation of nematode cell death. Mutations in ced-3 or
ced-4 abolish all somatic cell deaths that normally occur
during development, suggesting that these genes encode
activators or effectors of the cell death apparatus. By con-
trast, ced-9 functions as a negative regulator of ced-3 and
ced-4, preventing activation of the suicide response.
This cadre of cell death regulators adhere surprisingly
well to the metaphor of a suicide machine. The pro-apop-
totic CED-3 protein is the C elegans caspase, homolgous to
the larger family of mammalian caspases, and functions as
[ ]an effector of cell death in the nematode 16 . The CED-4
protein, although also a cold-blooded killer, functions as an
activator of CED-3 and thus, in effect, activates the cell
[ ]death machine 4,17,18 . Importantly, CED-4 possesses ho-
[ ]mology to the mammalian caspase activator, Apaf-1 19 .
And finally, the CED-9 protein, which is a homologue of
bcl-2, functions as an inhibitor of cell death in the nematode
[ ]14,20 . Emphasizing the evolutionary conservation of the
cell death pathway, bcl-2 can substitute functionally for
CED-9 in the nematode, thus partially blocking developmen-
[ ]tal cell death 20 .
Dying worms also provided some insight into a molecular
order for the cell death pathway. Epistasis analyses in the
nematode suggested that ced-9 functions genetically up-
[ ]stream of ced-3 and ced-4 21 . Consistent with this notion,
bcl-2 has been shown to function biochemically upstream of
[ ]certain mammalian caspases 22,23 . Ectopic expression of
CED-4 in C elegans neurons induces cell death, which
requires CED-3 activity, suggesting that CED-4 may func-
[ ]tion upstream of CED-3 24 . Furthermore, the CED-4 prod-
uct is required for CED-9 to block apoptosis, suggesting
that CED-9 may directly or indirectly regulate CED-4
[ ]activity 24 .
Whereas it was known that CED-3, CED-4, and CED-9
were critical components of the cell death machinery, it was
unclear how they were connected. Studies by several groups
showed that these core constituents interact and function in
a ternary death complex aptly named the apoptosome
[ ] ( )17,18,22,25–27 Figure 1, left . Similarly, in mammals, the
respective counterparts of the C elegans proteins,
[ ]caspase-9, Apaf-1, and bcl-2/x , mutually associate 28,29L
( )Figure 1, right . This cadre of core components in both C
elegans and mammals establishes a fundamental paradigm
that is likely recapitulated in the suicide pathway. In the
context of this review, the word apoptosome serves as a
theoretical construct referring to the sometimes transient
associations that constitute the ternary death apparatus,
rather than the assembly of smaller protein components into
(a larger functional complex i.e., ribosome, spliceosome,
)proteosome, etc. . Understanding the anatomy and regula-
tion of the apoptosome is a primary objective of this article.
In addition, how diverse death signals, specifically death
receptors, engage the apoptosome are also discussed.
Anatomy of the Apoptosome
Studies by several groups using various systems showed a
physical association between core components of the C
elegans death machine. In transfected mammalian cells,
insect cells, and yeast, CED-4 was shown to biochemically
interact with CED-9 and its mammalian counterparts bcl-2
[ ] ( )and bcl-x 25–27,30,31 Figure 1 . There are four distinctL
( ) [ ]bcl-2 homology BH regions that define the bcl-2 family 6
( )Figure 2 . CED-9 has distinct BH1, BH2, and BH4 do-
[ ] ( )mains, but not a BH3 domain 6 Figure 2 . Using two-hy-
brid analysis, Ottilie et al. showed that all 3 BH domains
found in CED-9 are necessary for the CED-9:CED-4 binding
[ ]32 . Similarly, alteration of the BH2 domain or the BH4
domain in bcl-x and bcl-2, respectively, blocks their abilityL
[ ]to bind CED-4 30,31 . Taken together, this would suggest
that prosurvival bcl-2 family members require intact BH1,
BH2, and BH4 domains to engage CED-4–like molecules.
Correlating with the biochemical interaction data, CED-9
and bcl-2/x negatively regulate CED-4 function as as-L
sessed by CED-4–induced apoptosis or caspase activation
[ ]17,18,30 . Inactivating mutations in CED-9 or bcl-2/x at-L
tentuated their ability to interact with CED-4. This linked an
inducer of cell death, CED-4, with classic inhibitors of the
suicide pathway. Importantly, this provided the first evi-
dence that the bcl-2 family may mechanistically function by
negatively regulating CED-4–like molecules. CED-9, like
bcl-2 and bcl-x , has a C-terminal hydrophobic tail and isL
(thought to reside on intracellular membranes including mi-
)tochondria . Thus it was shown that CED-9 regulates CED-4
subcellular localization, causing both molecules to colocal-
[ ]ize on membranes 25,33 .
Having seen that CED-4 interacted with CED-9, the next
logical step was to determine whether CED-4 could also
engage CED-3, the C elegans caspase. As with the
CED-4:CED-9 interaction, a number of investigators re-
ported the biochemical association between CED-4 and
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( ) ( )Figure 1. The apoptosome: A molecular framework for cell death C elegans left and mammals right . In C elegans,
CED-4 plays a crucial role as a molecular death switch, interacting with and assisting in the activation of the latent death
protease CED-3. CED-9 presumably interacts with and negatively regulates CED-4 function. EGL-1 can disrupt the
apoptosome by sequestering CED-9. With some added complexity, this primordial paradigm is likely recapitulated in
mammals. Unlike C elegans, the mammalian death machinery is complicated by redundancy. Bcl-x , bcl-2, and otherL
death suppressors of the bcl-2 family inhibit apoptosis by negatively regulating Apaf-1. By contrast, death-promoting
members of the bcl-2 family such as bid, bik, and bad antagonize the interactions between bcl-2/x and Apaf-1. In theL
absence of negative regulation, Apaf-1 is free to engage and activate the death protease, caspase-9. Cytochrome c and
ATP/dATP likely function as cofactors for the apoptosome. Once triggered, apical caspases such as caspase-9 activate
downstream small prodomain caspases.
[ ] ( )CED-3 18,30,34 Figure 1 . Both molecules have a shared
region of homology in their N terminus called a CARD
( )domain or caspase recruitment domain , which mediates
homophilic associations between death adaptors and cas-
( )pases Figure 2 . However, the interaction between CED-4
and CED-3 is somewhat complex with several sites of
contact and cannot merely be explained by a CARD-CARD
[ ]interaction 33 . As it was previously shown that CED-4
[ ]functioned upstream of CED-3 24 , it made good sense to
assume that CED-4 may function as a direct activator of
CED-3. Like the many mammalian caspases, CED-3 is
expressed as a single polypeptide zymogen, and, upon
proteolytic processing, gets converted into an active dimeric
protease. Consistent with this notion, CED-4 was shown to
Figure 2. Schematic representation of apoptosome constituents.
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both enhance CED-3–induced apoptosis and stimulate
[ ]CED-3 processing 4,17,18 . This ascribed CED-4 activity
could be negated by coexpression of CED-9.
Interestingly, CED-4 can interact independently and si-
multaneously with CED-3 and CED-9, forming a ternary
[ ] (death complex now known as the apoptosome 30 Figure
)1 . This triad of death conspirators was also found to colo-
[ ] (calize in cells 33 , with CED-9 and its hydrophobic C
)terminus dictating a membrane localization. Mutual interac-
tions between these core constituents provided a funda-
mental molecular framework for the cell death pathway.
Insight into the mammalian apoptosome comes not only
from analogy to the C elegans model, but also from an in
[ ]vitro apoptosis system used by Wang and coworkers 35 .
Addition of dATP to cell-free extracts derived from naive
Hela cells generated an apoptotic extract as assessed by its
ability to induce DNA fragmentation, elicit morphological
changes in nuclei, and activate the proapoptotic protease
caspase-3. Biochemical fractionation of these extracts re-
vealed 3 crucial apoptotic factors designated Apaf-1, Apaf-2,
and Apaf-3. The first identity revealed was Apaf-2, which
proved to be cytochrome c, now known as an important
[ ] (regulator of mammalian apoptosome function 35 dis-
)cussed later . Apaf-1 and Apaf-3 were revealed to be a
mammalian CED-4 and CED-3 homologue, respectively
[ ]19,36 . Although the designation for Apaf-1 has not
changed, Apaf-3, being a member of the growing caspase
family, is more commonly referred to as caspase-9. As
predicted by the molecular framework established in worms,
an equivalent ternary complex existed in mammals, com-
[ ] ( )posed of caspase-9, Apaf-1, and bcl-x 28 Figure 1 . OneL
caveat to this, however, is that full-length Apaf-1 interacts
with caspase-9 only in the presence of the apoptosome
[ ] ( )cofactors, cytochrome c and dATP 36 discussed later .
The observed coimmunoprecipitation of Apaf-1 and cas-
[ ]pase-9 in vivo 28 suggests that these cofactors were
present in this system.
What then happens when selected components of the
mammalian apoptosome are disrupted? Inactivation of cas-
pase-9 results in embryonic lethality and derangements in
[ ]brain development caused by decreased apoptosis 37,38 .
Caspase-9 -/- embryonic stem cells are resistant to various
forms of apoptosis and fail to activate the downstream
proapoptotic protease caspase-3. Furthermore, a number of
groups have shown that a dominant negative version of
capase-9, in which the catalytic cysteine is altered, blocks
diverse death signals including ultraviolet radiation, death
[ ]receptors, and proapoptotic bcl-2 family members 28,39 .
Apaf-1–deficient mice had an even more profound apop-
tosis-defective phenotype. In addition to being embryonic
lethal, inactivation of Apaf-1 caused a dramatic halt in
developmental cell death, leading to neuronal hyperplasia,
persistence of interdigital webs, dysregulation of eye devel-
[ ]opment, and severe craniofacial abnormalities 40,41 . As in
caspase-9–deficient mice, cells from Apaf-1–deficient mice
were resistant to a variety of apoptotic stimuli. It is important
to note, however, that the phenotype of the caspase-9 -/-
mice is not identical to the Apaf-1 -/- mice. In fact, it appears
that the defects in brain development seen in the caspase-9
-/- mice may represent a subset of the phenotype seen in
the Apaf-1 -/- mice, in which developmental apoptosis is
more significantly perturbed. An attractive hypothesis to
explain this discrepancy is that Apaf-1 may function to
activate more than one caspase, and thus its absence
would be equivalent to missing several caspases. Of
the caspases tested thus far, however, only caspase-9
has been shown to be autoproteolytically activated by
[ ]Apaf-1 39 .
(Although disrupting the killer genes caspase-9 and
)Apaf-1 causes decreased apoptosis in mice, inactivating
the prosurvival genes bcl-2 and bcl-x causes inappropriateL
cellular suicide. Bcl-2–deficient mice develop normally but
later in life exhibit increased lymphoid apoptosis among
[ ]various other tissue abnormalities 6,42 . By contrast, inacti-
vation of bcl-x leads to embryonic lethality consequent toL
[ ]massive neuronal and erythroid cell apoptosis 43 . Taken
together, inactivation of apoptosome components in mam-
mals generally correlates with the phenotype predicted by
nematode genetics. One caveat to this statement is the
added complexity in mammals due to a redundancy inher-
ent in their cell death pathway.
EGL-1 As a Signal Integrator for the Apoptosome
If prosurvival members of the bcl-2 family function by inter-
acting with and inhibiting CED-4–like molecules, then how
do proapoptotic bcl-2 members, such as bax, bik, and bid,
function? These death-inducing bcl-2 family members all
share a region of homology called the BH3 domain, which is
important both for their interaction with bcl-2–like molecules
and for their ability to trigger cell death. One hypothesis is
that pro-apoptotic bcl-2 family members may function by
interacting with bcl-2/x and preventing it from bindingL
CED-4–like molecules. By disengaging a CED-4–like killer,
the death pathway would then be activated. In support of
this hypothesis, expression of the death-promoting bcl-2
family members, bax, bak, or bik, was shown to abrogate
[ ] [ ]the bcl-x association with either CED-4 30 or Apaf-1 28 .L
A dominant negative version of caspase-9 inhibited bax-,
bak-, and bik-induced cell death, suggesting that pro-apop-
totic bcl-2 family members transmit a death signal via the
[ ]apoptosome 28 . In sum total, this would suggest that
BH3-containing killer molecules induce cell death by com-
mandeering bcl-2/x and thus releasing Apaf-1 to activateL
procaspase-9.
Proof of concept came with studies in the nematode in
which EGL-1 was identified as a C elegans protein that
contains a BH3 domain and is functionally similar to other
[ ] ( )proapoptotic bcl-2 family members 44 Figure 2 . Mutation
of the egl-1 gene in worms blocks most if not all somatic cell
death during nematode development. Gain of function muta-
tions in egl-1 results in apoptosis of a specific neuronal
[ ]population in nematodes 44 . Ectopic expression of EGL-1
in C elegans mechanosensory cells induces cell death,
which requires CED-3 and CED-4 activity, suggesting that
EGL-1 functions upstream of both these molecules. In addi-
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tion, the CED-9 product is required for EGL-1 to induce
apoptosis, intimating that EGL-1 may function by directly or
indirectly inactivating CED-9. Taken together, this would
suggest that EGL-1 functions upstream of the apoptosome
in general, making it one of the earliest acting components
of the nematode death apparatus thus far identified.
Biochemical interaction data on EGL-1 confirmed the
predictions made genetically. EGL-1 was shown to physi-
[ ]cally associate with CED-9 44,45 . By doing so, EGL-1
disrupts the apoptosome, thus interfering with the
CED-9:CED-4 association, an activity that required the BH3
[ ]domain of EGL-1 45 . This in effect activates the apopto-
some by disengaging CED-4, allowing it to promote CED-3
( )processing and thus induce cell death Figure 3 . EGL-1 did
not have independent associations with either CED-3 or
CED-4 and functioned as an inducer of apoptosis only
through its interactions with CED-9. In the presence of
CED-9, CED-4 localizes to intracellular membranes. How-
(ever, when EGL-1 is added to the mix, CED-4 and presum-
) [ ]ably associated CED-3 gets shifted to the cytosol 45 . In a
latent, inactive state, the ternary suicide complex is assem-
( )bled on intracellular membranes including on mitochondria .
Expression of EGL-1 would then negate CED-9 function
and thus liberate CED-4 and CED-3, allowing them to
induce cell death.
The identification and characterization of EGL-1 in C
elegans define an emerging class of cell death activators
that function by disrupting the mutual associations present
in the apoptosome. Importantly, EGL-1 appears to be a
required element of the nematode suicide appartus. Worms
with defective EGL-1 are unable to undego normal develop-
mental cell death, suggesting that EGL-1 activity is crucial in
unleashing the death potential of the apoptosome. The
requirement of an intact BH3 domain makes EGL-1 func-
tionally analogous to other proapoptotic bcl-2 family mem-
bers such as bax, bid, or bik. Interestingly, egl-1 was found
to function downstream of two genes involved in specifying
[ ]nematode cell death fate, ces-1 and ces-2. 44 . Thus, this
would suggest that EGL-1 may represent a primordial inte-
grator of the suicide signal. It will be important to determine
how these and other death-inducing signals funnel into the
pathway of cell death regulated by EGL-1. If a similar
analogy is applied to mammals, one could speculate that
the growing family of proapoptotic bcl-2 family members
may each transduce differing death signals. Bid, for exam-
ple, has been shown to in transmit the suicide signal from
[ ] (cell death receptors to the apoptosome 46–48 discussed
)later . The existence of numerous proapoptotic bcl-2 family
( )members or EGL-1–like molecules emphasizes the redun-
dancy present in mammalian apoptosis pathways.
An Induced Proximity Model for Apoptosome Function
Although it appears that EGL-1 functions to liberate the
( )killer proteins CED-3 and CED-4 from sequestration by the
( )protective protein CED-9 , the mechanism by which the
killers are then activated remains to be determined. Studies
of the proximal signaling machinery of the cell surface death
( ) [ ]receptor CD95 Fas/Apo-1 provided the answer 8,9 . In
this pathway, CD95 gets aggregated extracellularly by its
natural ligand, CD95L, or agonist antibody. This then re-
cruits the cytoplasmic death adpator molecule FADD
( )Fas-associated death domain protein to the cell surface
(signaling complex. Through homophilic DED death effector
)domain associations, FADD then oligomerizes and acti-
( )vates the proapoptoic protease caspase-8 FLICE/MACH
( )Figure 4, top . Aggregation of FADD increases the local
concentration of caspase-8 in a microenvironment, harness-
ing the low proteolytic activity inherent in the caspase-8
[ ]zymogen to promote intermolecular processing 49 . In other
(Figure 3. The C elegans apoptosome and its mechanism of activation. In the inactive state the ternary complex CED-3,
)CED-4, and CED-9 is assembled on mitochondria. An unspecified death signal mobilizes EGL-1. In turn, EGL-1 binds
CED-9, disengaging the apoptosome. CED-4 proceeds to oligomerize and induce the proximity and consequent activation
of proCED-3 molecules.
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( )Figure 4. The mammalian apoptosome and its interface with the CD95 pathway. 1: Unactivated CD95 Fas /APO-1
expressed on the cell surface. DD, death domain. DED, death effector domain. 2: Formation of the CD95 death-signaling
complex after trimerization by CD95L. Initially, the death adaptor FADD is recruited the cytoplasmic domain of CD95.
FADD in turn induces proximity among procaspase-8 molecules, leading to 3: proteolytic activation. 4: Active caspase-8
then cleaves small-prodomain caspases, leading to cell death. 5: Alternatively, caspase-i can cleave the bcl-2 homologue
( ) ( )Bid. 6: Once Bid is proteolytically cleaved to tBid truncated it can bind bcl-x . In the inactive state A , Apaf-1 is in aL
closed conformation bound to bcl-x . The asterisk represents the P-loop motif. CARD, caspase recruitment domain. UponL ( )death stimulus, cytochrome c is released from mitochondria B . Likewise, death signals mobilize proapoptotic members of
( )the bcl-2 family, such as Bid, to disrupt the latent apoptosome C . Cytochrome c and/or dATP/ATP hydrolysis induces a
( )conformational change in Apaf-1, negating the inhibitory effect of the WD-40 repeats black boxes in the Apaf-1 molecule .
( )In the open conformation and liberated of bcl-x inhibition, Apaf-1 is free to self-associate via its CED-4–like domain D .L
CARD-CARD associations link Apaf-1 to procaspase-9. Oligomerization of Apaf-1 aggregates procaspase-9, leading to its
( )proteolytic activation E and consequent induction of cell death.
words, by inducing a proximity among caspase-8 molecules,
FADD likely enhances proteolytic self-activation of procas-
[ ]pase-8 49,50 .
This paradigm for caspase activation is used by and
likely originates from the apoptosome. Studies that used the
C elegans components showed that CED-4 can self-associ-
[ ]ate through amino acids 171-435 51 . CED-9 functioned to
prevent CED-4 oligomerization. As the caspase CED-3 is
tethered to CED-4, oligomerization presumably induces
proximity of CED-3 zymogens favoring proteolytic
( )self-activation see Figure 3 . Mutations that abolished
CED-4 oligomerization also prevented CED-4–mediated
activation of CED-3.
A somewhat more complex scenario exists in mammals.
Full-length Apaf-1 requires dATP and cytochrome c to
[ ]promote caspase-9 activation in vitro 36 . Unlike CED-4,
the C-terminal half of Apaf-1 contains a stretch of 12 WD-40
repeats, which is a motif often involved in protein-protein
( )interactions see Figure 2 . A truncated Apaf-1 molecule
( )N-Apaf-1, a.a.1-559 , in which the WD-40 repeats are ab-
(sent, constitutively activates caspase-9 in vitro without cy-
) [ ]tochrome c and dATP dependence 39,52 . This truncated
Apaf-1 was shown to oligomerize via its CED-4 homology
domain and, analogous to CED-4, was thought to activate
( )procaspase-9 by inducing proximity Figure 4 . Disruption of
the self-association domain in Apaf-1 abrogated its ability to
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activate procaspase-9. The association between Apaf-1
and caspase-9 is mediated by CARD-CARD interactions
[ ] ( )36 see Figure 2 . Expressed alone, the Apaf-1 CARD
domain, which does not oligomerize, failed to induce
[ ]caspase-9 processing 39,52 . As predicted, however,
(if this CARD domain is aggregated by using various
)oligomerization systems , procaspase-9 can then be effi-
[ ]ciently activated 52 .
Whereas N-Apaf-1 appears to function similarly to other
oligomerizing molecules such as FADD or CED-4, the role
of the C-terminal half of Apaf-1, which encompasses the
( )WD-40 repeats, remains to be deciphered see Figure 2 .
Unlike the N-Apaf-1, full-length Apaf-1 fails to interact with
and activate caspase-9 alone but requires the presence of
[ ]dATP and cytochrome c 36 . This suggested that the
WD-40 repeats may function as a negative regulator of
Apaf-1. Consistent with this, Hu et al. show that the WD-40
repeats bind to and negatively regulate N-Apaf-1, negating
[ ] (its ability to oligomerize or activate procaspase-9 52 Fig-
)ure 4 . Although it is evident that the WD-40 repeats bind
the N terminus of Apaf-1, it remains to be determined
whether they function competitively, directly binding to the
Apaf-1 oligomerization domain. Alternatively, by binding to
an adjacent site, they may mask the oligomerization domain
via steric hinderance. As suggested by Hu et al., these
findings support an attractive model in which Apaf-1 exists
[ ] ( )in 2 distinct conformations 52 Figure 4 . In the closed
conformation, the WD-40 repeats bind to the N terminus of
Apaf-1, keeping it in an inactive, latent state. By contrast, in
the open conformation, the N terminus of Apaf-1 is liberated
and can subsequently self-oligomerize and aggregate pro-
( )caspase-9 Figure 4 . Interestingly, because dATP and cy-
tochrome c are required for full-length Apaf-1 activity, they
may serve as important cofactors that facilitate the shift
from the closed to open conformation.
Cofactors of Apoptosome Function: ATP/dATP
(The three known CED-4 sequences C elegans, C brig-
)gsae, and C vulgaris and Apaf-1 contain a nucleotide-bind-
( )ing phosphate-loop, P-loop motif characteristic of adeno-
( )sine triphosphatases ATPases and guanosine triphos-
( ) [ ]phatases GTPases 53 . In addition, downstream of each
P-loop exists a potential Mg2q binding motif typical of a
[ ]large class of ATPases 53 and consisting of two aspartic
acid residues preceded by 4 bulky hydrophobic residues
( )see Figure 2 . Interestingly, database searches with CED-4
( )and Apaf-1 identified a class of plant resistance R gene
[ ]products 2,4 . These R gene products are important com-
ponents of the hypersensitive response, which is a mecha-
nism induced by certain plant pathogens and involving cell
[ ]death to restrict pathogen spread 54 . In addition to being
homologous in the P-loop and Mg2q binding domain, these
(plant resistance response genes including PRF, RPM1,
)and L6 also have several other short conserved regions
[ ]homologous to CED-4/Apaf-1 2 . Of note, a number of
these R gene products have C terminal leucine-rich repeats,
which, analogous to the WD-40 repeats of Apaf-1, are
[ ]involved in protein-protein interactions 2 . The presence of
a conserved ATPase domain in CED-4/Apaf-1 and the R
response proteins suggests there may be mechanistic simi-
larities between the suicide apparatus in animals and plants.
In support of this somewhat stunning notion, a caspase-like
activity has been identified in hypersensitive response-re-
[ ]lated plant cell death 3 .
Whereas CED-4 has been shown to bind ATP analogues
[ ]4 , no one has been able to formally show ATPase activity
for the molecule. Mutation of the P-loop in CED-4 abolishes
its ability to induce cell death and stimulate CED-3 process-
ing, verifying the functional relevance of this domain
[ ]4,17,26,30 . The CED-4 P-loop mutants fail to both bind
( )CED-9 and interact with the prodomain or CARD of CED-3
[ ]33 . Interestingly, altering the P-loop in CED-4, does not
[ ]affect CED-4 self-association 51 . The P-loop, however,
does appear to be an important point of regulation in the
CED-4 molecule.
By contrast to CED-4, alteration of the P-loop in N-Apaf-1
[ ]abolishes its ability to oligomerize 52 . The reason for this
difference is unclear but may have to do with varied levels
of expression between the two proteins in mammalian tras-
fection systems. Interestingly, mutation of the P-loop abro-
[ ]gates the activity of the mammalian expressed protein 52
but only slightly diminishes the activity of the bacterially
[ ]expressed protein 39 . This discrepancy could be due to
the higher expression levels achieved in bacteria, forcing
aggregation independent of self-association. Thus at higher
expression levels, N-Apaf-1 may bypass the requirement of
nucleotide binding and still oligomerize. This also suggests
that the nucleotide-binding pocket of Apaf-1, which spans
the CED-4–like homology region, may contribute to the
( )structure of the oligomerization surface see Figure 2 .
What is the role of dATP or ATP hydrolysis in apopto-
some function? In the original in vitro model of apoptosis
[ ]35 , dATP was found to be a required component. Further-
more, studies suggest that dATP or ATP hydrolysis is nec-
[ ]essary for caspase-9 activation by full-length Apaf-1 36 ,
[ ]but not by the truncated derivative N-Apaf-1 39,52 . Thus,
ATP/dATP hydrolysis could provide the energy required to
overcome negative regulation of Apaf-1 by the WD-40 re-
peats, promoting an open conformation over a closed one
[ ]52 . Alternatively, ATP/dATP hydrolysis may be needed to
disengage the proteolytically activated caspase-9 from the
apoptosome. Consistent with this hypothesis, Srinivasula et
al. demonstrated that N-Apaf-1–activated caspase-9 re-
mains bound to N-Apaf-1 and is unable to cleave its down-
[ ]stream target caspase-3 39 .
Cofactors of Apoptosome Function: Cytochrome c
Discovery of cytochrome c as a component of the cell death
pathway sent shock waves through the field of apoptosis
[ ]research 35 . Traditionally thought of as an integral part of
electron transport chain, cytochrome c resides in the space
between the inner and outer mitochondrial membranes.
During apoptosis, cytochrome c is translocated, almost en-
tirely, to the cell cytosol by a thus-far unknown mechanism.
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Once in the cytosol, cytochrome c serves as important
instigator of the cell death pathway by binding to and en-
[ ]abling the central apoptosome component Apaf-1 19 . Like
dATP, cytochrome c is not a requirement for the functional-
[ ]ity of the constitutively active N-Apaf-1 39 . This would
suggest that, alone or in combination with dATP, cy-
tochrome c facilitates the conversion of Apaf-1 from the
inactive, closed conformation to the active, open conforma-
tion, freeing the N terminus of Apaf-1 from negative regula-
( )tion by the WD-40 repeats Figure 4 . Where cytochrome c
precisely interacts with Apaf-1 is unclear, but a purely spec-
ulative model would suggest it interacts with and negates
( )the function of the WD-40 repeats Figure 4 . Cytochrome
c, which is positively charged, physically interacts with
its electron transport partners cytochrome reductase and
[ ]cytochrome oxidase, which are negatively charged 55 .
It would be interesting to determine whether analogous
electrostatic interactions exist between cytochrome c
and Apaf-1.
The finding that cytochrome c is an important
apoptosis-mediator opens up a can of worms in the study of
( )cell death no pun intended . This electron carrier is present
in all organisms that have mitochondrial respiratory chains:
plants, animals, and eucaryotic organisms. It is strictly con-
served among various species, with 26 of 104 residues
(being invariant for over 1.5 billion years before the diver-
) [ ]gence of plants and animals 55 . In terms of function,
cytochrome c from any eukaryotic species can interact with
[ ]any cytochrome oxidase 55 . Thus it is intriguing that cy-
tochrome c from several vertebrate species, but not from
yeast, was able to initiate an in vitro system of apoptosis
[ ]56 . It is unclear, whether C elegans cytochrome c is
released during apoptosis and whether it binds to CED-4.
Furthermore the electron transport activity of cytochrome c
[ ]is not required for its proapoptoic activity 56 .
Cytochrome c, while still being translocated to the cy-
tosol, is unable to trigger the apoptotic pathway in the
[ ]absence of Apaf-1 or caspase-9 38,41 , suggesting that it
functions upstream of these molecules. Furthermore, in the
presence of the broad spectrum caspase inhibitor
z-VAD-fmk, cytochrome c is still released from mitochondria
[ ]57 . Hence, although key components of the apoptosome
are missing or inactivated, cytochrome c can still be liber-
ated, intimating that death signals in general must have
some cytochrome c–releasing mechanism, independent of
the apoptosome. Importantly, overexpression of bcl-2 has
been shown to block cytochrome c release in response to a
[ ]variety of death signals 58,59 . How bcl-2 manages to
block cytochrome c release and keep the apoptosome
inactive is unclear. Some clues may come from studies
(examining the proapoptotic bcl-2 family member bid dis-
)cussed in more detail in the following section .
Death Receptors Interface With the Apoptosome
As described earlier, CD95 is a prototypic member of the
death receptor family and signals apoptosis via engagement
of the death adaptor FADD which in turn recruits the death
protease caspase-8. Once caspase-8 is activated it can
then proteolytically activate a cascade of caspases leading
( )to the phenotype of apoptosis Figure 4 . Recently, several
groups identified Bid, a previously characterized proapop-
totic molecule of bcl-2 family, as a novel substrate for
caspase-8. Bid, a bcl-2 interacting protein, is a mammalian
counterpart to C elegans EGL-1 and one of the ‘‘BH3-only’’
[ ]death-promoting bcl-2 family members 46,47,60 . Interest-
ingly, when cytosolic Bid is cleaved by caspase-8 it is
translocated to mitochondria and mediates the release of
( )cytochrome c Figure 4 . Bid-induced apoptosis is inhibited
by bcl-2, bcl-x , and a dominant negative derivative ofL
caspase-9.
( )When recombinant truncated Bid tBid is added to puri-
fied mitochondria in vitro, cytochrome c release is induced
[ ]46 . The mechanism by which Bid achieves this is unclear.
Some have suggested that gross mitochondrial swelling and
permeability transition, which occur in the late phases of the
apoptotic phenotype, may be the cause of cytochrome c
[ ]release 61–63 . In the case of Bid, however, this does not
occur, because cytochrome c can be liberated without the
[ ]loss of mitochondrial membrane potential 46,47 . It will be
interesting to determine whether this phenomena of cy-
tochrome c release in vitro, can be recapitulated by other
death-promoting bcl-2 family members. In addition, Bid can
(presumably also function like EGL-1 and killer bcl-2 family
)members to disrupt the apoptosome. By binding to bcl-2/x ,L
Bid likely disengages the apoptosome, allowing Apaf-1 to
( )oligomerize and activate caspase-9 Figure 4 .
Bid needs to be cleaved in order to gain full apoptotic
[ ] ( )potential 46 . The C terminal fragment Bid Figure 2 , which
contains the BH3 domain, then gets recruited to mitochon-
dria. Previous studies have shown that Bax similarly gets
[ ]translocated to mitochondria after a death stimulus 64 .
This suggests that death-promoting members of the bcl-2
( )family EGL-1 included have an inactive state which has to
undergo a molecular alteration, either removal of an in-
hibitory domain or conformational change, in order to be
activated.
Bid links the cell surface death receptors to mitochondria
and the apoptosome. Death receptors such as CD95 likely
signal apoptosis by 2 distinct pathways. One is by activation
of caspase-8, which in turn activates downstream caspases
by proteolytic cleavage ultimately resulting in cell suicide.
Alternatively, caspase-8 can cleave Bid, which functions to
release cytochrome c and disrupt the apoptosome resulting
( )in caspase-9 activation and cell death Figure 4 . Thus, in
the former scenario, death receptors use Bid to amplify the
suicide signal. This was initially suggested by in vitro stud-
ies that showed that caspase-8–induced apoptosis can be
amplified through mitochondrial release of cytochrome c
[ ]65 . Depending on the cell type, one death receptor path-
[ ]way may be preferred over the other 66 . Bcl-2 and bcl-xL
inhibit death receptor-induced apoptosis in some cells but
[ ]not in others 66 . One would predict that bcl-2 and bcl-xL
may exert their protective effect in cells where the Bid
signaling pathway predominates. For example, in MCF7
breast carcinoma cells, bcl-x inhibits CD95- and tumorL
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necrosis factor receptor 1–induced apoptosis downstream
[ ]of caspase-8 activation 67 , presumably by inhibiting the
ability of Bid to disengage the apoptosome and release
cytochrome c.
Conclusions
Apoptosis as a biological process was first defined years
ago by Wyllie and colleagues. Until recently, little was
known about the molecular mechanism behind this elegant
phenomena. Over the past few years many important ad-
vances have been made in understanding the inner work-
ings of the suicide apparatus.
The nematode model system laid the foundation for much
of what is known about the cell death pathway today. By
using this powerful genetic screen, three core components
of the suicide apparatus were identified CED-3, CED-4 and
CED-9. The caspase CED-3 is the effector of cell death in
the nematode and acts as a molecular executioner. A co-
conspirator to murder, CED-4, functions to activate CED-3.
By contrast, the law enforcement authority, CED-9, inhibits
the death pathway by keeping CED-4 in check. These three
components mutually associate in the molecular dance of
death called the apoptosome. EGL-1, a new suspect in this
murder mystery, functions by binding CED-9 and disrupting
the interactions of the ternary death complex. Thus, in the C
elegans paradigm of death, EGL-1 can be mobilized by
various unspecified suicide signals. By binding CED-9,
EGL-1 disrupts the latent, inactive apoptosome. Once CED-4
is disengaged from CED-9-inhibition, it oligomerizes and
induces proximity among CED-3 molecules causing
auto-proteolytic activation and consequent cell death.
If the cell death pathway is conserved throughout evolu-
tion, then it is reasonable to postulate that the primordial
suicide paradigm established in nematodes would be reca-
pitulated in higher organisms. The mammalian apoptosome
is made of a similar cast of characters including an effector,
caspase-9; an activator, Apaf-1; and an inhibitor, bcl-2/x .L
Death-promoting members of the bcl-2 family such as bax,
bid, and bik likely function as disruptors of the apoptosome,
analogous to C elegans EGL-1. In summary, bcl-2 main-
tains an inactive, latent apoptosome. Upon death stimulus,
a bcl-2 antagonist presumably liberates Apaf-1 and releases
cytochrome c from mitochondria. Once disengaged, Apaf-1
is free to oliogmerize and thus aggregate and activate
parocaspase-9, ultimately resulting in cell suicide.
Whereas the basic molecular framework has been in-
stalled, numerous questions still lurk in the background. For
example, what is the mechanism of cytochrome c release
from mitochondria? How do bcl-2 antagonists, such as Bid,
mediate release of cytochrome c, in addition to disrupting
the apoptosome? Do the other pro-apoptotic members of
the bcl-2 family mimic the activity of Bid? What exactly is
the role of cytochrome c and ATP/dATP in apoptosome
function? These and other questions will continue to fuel the
morbid curiosity of cell death researchers.
In the big picture, however, it will be important to deter-
mine how diverse death signals impinge upon the ‘‘heart
and soul’’ of the cell death machine. In C elegans it is
unclear how the regulators of cell death fate engage EGL-1
and thus activate the apoptosome. Although a number of
apoptotic triggers are well characterized, including death
receptors, growth factor withdrawal, p53 and chemothera-
peutics, it is unclear how they are connected to the core
machinery. A model for how death receptors interface with
the apoptosome has already been proposed: activation of
the bcl-2 antagonist, Bid. It is tempting to speculate that
each of the pro-apopotic bcl-2 family members may couple
to a different upstream death signaling pathway, thus acting
as distinct signal integrators. Characterizing the precise
molecular circuitry of the cell death pathway will facilitate
the design of rational therapies for cancer and other human
disease states in which apoptosis plays an important role.
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